<p>CVRx（纳斯达克代码：CVRX - 获取免费报告）于周三发布了季度财报。公司报告本季度每股收益为（$0.49），超出市场共识预期的（$0.50）$0.01，FiscalAI 报道。公司本季度收入为 1469 万美元，而市场共识预期为 1416 万美元。CVRx 的净利润率为-95.61%，股本回报率为-79.31%。CVRx 更新了其 2025 年第四季度的每股收益指引，并将其 2025 财年的每股收益指引进行了更新。</p>
<h2>CVRx 股票表现</h2>
<p>周三午盘交易中，CVRX 股票下跌 0.20 美元，报 9.79 美元。该股票交易量为 227,522 股，而其平均交易量为 290,381 股。CVRx 的 1 年最低价为 4.30 美元，1 年最高价为 18.55 美元。公司的债务与股本比率为 0.85，流动比率为 11.99，速动比率为 10.78。该公司的市值为 2.5603 亿美元，市盈率为-4.66，贝塔系数为 1.28。该股票的 50 日简单移动平均线为 8.61 美元，200 日简单移动平均线为 7.49 美元。</p>
<h2>分析师设定新目标价</h2>
<p>多家研究机构最近对 CVRX 进行了评估。Weiss Ratings 在 10 月 30 日的研究报告中重申了对 CVRx 股票的 “卖出（e+）” 评级。Cantor Fitzgerald 在 8 月 5 日的研究报告中重申了 “增持” 评级，并设定了 CVRx 股票的目标价为 11.00 美元。一位分析师给予该股票 “强烈买入” 评级，五位分析师给予 “买入” 评级，两位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 14.00 美元。</p>
<p><strong>阅读我们关于 CVRx 的最新研究报告</strong></p>
<h2>机构投资者对 CVRx 的看法</h2>
<p>多家机构投资者最近调整了对 CVRX 的持股。XTX Topco Ltd 在第二季度收购了 CVRx 的新股份，价值约为 155,000 美元。Cresset Asset Management LLC 在第二季度将其在 CVRx 的持股增加了 3.5%。Cresset Asset Management LLC 目前拥有 53,542 股公司股票，价值为 315,000 美元，此前在该期间内购买了 1,823 股。美国银行（Bank of America Corp DE）在第二季度将其在 CVRx 的持股增加了 7.6%。美国银行（Bank of America Corp DE）目前拥有 89,049 股公司股票，价值为 524,000 美元，此前在该期间内收购了 6,312 股。Marshall Wace LLP 在第二季度将其在 CVRx 的持股增加了 238.1%。Marshall Wace LLP 目前拥有 350,080 股公司股票，价值为 2,058,000 美元，此前在该期间内收购了 246,548 股。最后，Geode Capital Management LLC 在第二季度将其在 CVRx 的持股增加了 6.4%。Geode Capital Management LLC 目前拥有 382,437 股公司股票，价值为 2,249,000 美元，此前在该期间内收购了 23,079 股。当前 75.27% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 CVRx</h2>
<p>（获取免费报告）</p>
<p>CVRx, Inc 是一家商业阶段的医疗设备公司，专注于为心血管疾病患者开发、制造和商业化神经调节解决方案。该公司提供 Barostim，这是一种神经调节设备，旨在改善射血分数降低或收缩性心力衰竭患者的症状。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票比 CVRx 更好</li>
<li>万亿美元市值的意义超越数字</li>
<li>目前现金充裕的三只高增长潜力股票</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>为什么垂直航空股票在这次飞行测试后可能会翻倍</li>
<li>经纪排名在股票选择中的重要性</li>
<li>亚马逊：突破确认——它可能会去哪里</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1ZSWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1ZSWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CVRx 吗？</h2>
<p>在你考虑 CVRx 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 CVRx 并不在名单上。</p>
<p>虽然 CVRx 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

CVRX

<p>CVRx（纳斯达克代码：CVRX）报告季度每股收益为（$0.49），超出预期的（$0.50）$0.01。公司实现收入 1469 万美元，超过预期的 1416 万美元。尽管股本回报率为负 79.31%，净利润率为 95.61%，CVRx 更新了 2025 年第四季度的指引。股票交易下跌至$9.79，市值为 2.5603 亿美元。分析师对该股的共识评级为 “适度买入”，目标价为$14.00。机构投资者持有 75.27% 的股份</p>

<p>CVRx (NASDAQ:CVRX - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.49) earnings per share for the quarter, topping the consensus estimate of ($0.50) by $0.01, FiscalAI reports. The company had revenue of $14.69 million for the quarter, compared to the consensus estimate of $14.16 million. CVRx had a negative net margin of 95.61% and a negative return on equity of 79.31%. CVRx updated its Q4 2025 guidance to EPS and its FY 2025 guidance to EPS.</p>
<div class="lb-trans"><p>CVRx（纳斯达克代码：CVRX - 获取免费报告）于周三发布了季度财报。公司报告本季度每股收益为（$0.49），超出市场共识预期的（$0.50）$0.01，FiscalAI 报道。公司本季度收入为 1469 万美元，而市场共识预期为 1416 万美元。CVRx 的净利润率为-95.61%，股本回报率为-79.31%。CVRx 更新了其 2025 年第四季度的每股收益指引，并将其 2025 财年的每股收益指引进行了更新。</p>
</div><h2>CVRx Stock Performance</h2>
<div class="lb-trans"><h2>CVRx 股票表现</h2>
</div><p>CVRX stock traded down $0.20 during midday trading on Wednesday, hitting $9.79. 227,522 shares of the stock traded hands, compared to its average volume of 290,381. CVRx has a 1-year low of $4.30 and a 1-year high of $18.55. The company has a debt-to-equity ratio of 0.85, a current ratio of 11.99 and a quick ratio of 10.78. The firm has a market cap of $256.03 million, a P/E ratio of -4.66 and a beta of 1.28. The stock's fifty day simple moving average is $8.61 and its 200-day simple moving average is $7.49.</p>
<div class="lb-trans"><p>周三午盘交易中，CVRX 股票下跌 0.20 美元，报 9.79 美元。该股票交易量为 227,522 股，而其平均交易量为 290,381 股。CVRx 的 1 年最低价为 4.30 美元，1 年最高价为 18.55 美元。公司的债务与股本比率为 0.85，流动比率为 11.99，速动比率为 10.78。该公司的市值为 2.5603 亿美元，市盈率为-4.66，贝塔系数为 1.28。该股票的 50 日简单移动平均线为 8.61 美元，200 日简单移动平均线为 7.49 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of research firms have recently weighed in on CVRX. Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of CVRx in a research note on Thursday, October 30th. Cantor Fitzgerald reaffirmed an &#34;overweight&#34; rating and set a $11.00 price target on shares of CVRx in a research report on Tuesday, August 5th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $14.00.</p>
<div class="lb-trans"><p>多家研究机构最近对 CVRX 进行了评估。Weiss Ratings 在 10 月 30 日的研究报告中重申了对 CVRx 股票的 “卖出（e+）” 评级。Cantor Fitzgerald 在 8 月 5 日的研究报告中重申了 “增持” 评级，并设定了 CVRx 股票的目标价为 11.00 美元。一位分析师给予该股票 “强烈买入” 评级，五位分析师给予 “买入” 评级，两位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 14.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on CVRx</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CVRx 的最新研究报告</strong></p>
</div><h2>Institutional Investors Weigh In On CVRx</h2>
<div class="lb-trans"><h2>机构投资者对 CVRx 的看法</h2>
</div><p>A number of institutional investors have recently modified their holdings of CVRX. XTX Topco Ltd acquired a new stake in CVRx in the second quarter valued at approximately $155,000. Cresset Asset Management LLC grew its holdings in CVRx by 3.5% in the second quarter. Cresset Asset Management LLC now owns 53,542 shares of the company's stock valued at $315,000 after purchasing an additional 1,823 shares during the period. Bank of America Corp DE grew its stake in CVRx by 7.6% in the 2nd quarter. Bank of America Corp DE now owns 89,049 shares of the company's stock valued at $524,000 after acquiring an additional 6,312 shares during the period. Marshall Wace LLP grew its stake in CVRx by 238.1% in the 2nd quarter. Marshall Wace LLP now owns 350,080 shares of the company's stock valued at $2,058,000 after acquiring an additional 246,548 shares during the period. Finally, Geode Capital Management LLC grew its stake in CVRx by 6.4% in the 2nd quarter. Geode Capital Management LLC now owns 382,437 shares of the company's stock valued at $2,249,000 after acquiring an additional 23,079 shares during the period. 75.27% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>多家机构投资者最近调整了对 CVRX 的持股。XTX Topco Ltd 在第二季度收购了 CVRx 的新股份，价值约为 155,000 美元。Cresset Asset Management LLC 在第二季度将其在 CVRx 的持股增加了 3.5%。Cresset Asset Management LLC 目前拥有 53,542 股公司股票，价值为 315,000 美元，此前在该期间内购买了 1,823 股。美国银行（Bank of America Corp DE）在第二季度将其在 CVRx 的持股增加了 7.6%。美国银行（Bank of America Corp DE）目前拥有 89,049 股公司股票，价值为 524,000 美元，此前在该期间内收购了 6,312 股。Marshall Wace LLP 在第二季度将其在 CVRx 的持股增加了 238.1%。Marshall Wace LLP 目前拥有 350,080 股公司股票，价值为 2,058,000 美元，此前在该期间内收购了 246,548 股。最后，Geode Capital Management LLC 在第二季度将其在 CVRx 的持股增加了 6.4%。Geode Capital Management LLC 目前拥有 382,437 股公司股票，价值为 2,249,000 美元，此前在该期间内收购了 23,079 股。当前 75.27% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About CVRx</h2>
<div class="lb-trans"><h2>关于 CVRx</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CVRx, Inc, a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure.</p>
<div class="lb-trans"><p>CVRx, Inc 是一家商业阶段的医疗设备公司，专注于为心血管疾病患者开发、制造和商业化神经调节解决方案。该公司提供 Barostim，这是一种神经调节设备，旨在改善射血分数降低或收缩性心力衰竭患者的症状。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than CVRx</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>3 Cash-Rich Stocks With High Growth Potential Right Now</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Why Vertical Aerospace Stock Could Double After This Flight Test</li>
<li>The Significance of Brokerage Rankings in Stock Selection</li>
<li>Amazon: Breakout Confirmed—Here’s Where It Could Go Next</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 CVRx 更好</li>
<li>万亿美元市值的意义超越数字</li>
<li>目前现金充裕的三只高增长潜力股票</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>为什么垂直航空股票在这次飞行测试后可能会翻倍</li>
<li>经纪排名在股票选择中的重要性</li>
<li>亚马逊：突破确认——它可能会去哪里</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1ZSWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CVRX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVRx Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVRx 吗？</h2>
</div><p>Before you consider CVRx, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CVRx 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVRx wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 CVRx 并不在名单上。</p>
</div><p>While CVRx currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVRx 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

CVRx（NASDAQ: CVRX）公布季度财报，每股收益比预期高出 0.01 美元